Preprint Article Version 1 This version is not peer-reviewed

Antinociceptive Potential of Ximenia americana L. Bark Extract and Caffeic Acid: Insights into Pain Modulation Pathways

Version 1 : Received: 6 November 2024 / Approved: 7 November 2024 / Online: 7 November 2024 (16:33:46 CET)

How to cite: Pessoa, R. T.; Santos da Silva, L. Y.; Alcântara, I. S.; Silva, T. M.; Silva, E. D. S.; Costa, R. H. S. D.; da Silva, 7. B.; Ribeiro-Filho, J.; Pereira Bezerra Martins, A. O. B.; Coutinho, H. D. M.; Sousa, J. C. P.; Chaves, A. R.; Marreto, R. N.; Menezes, I. R. A. D. Antinociceptive Potential of Ximenia americana L. Bark Extract and Caffeic Acid: Insights into Pain Modulation Pathways. Preprints 2024, 2024110552. https://doi.org/10.20944/preprints202411.0552.v1 Pessoa, R. T.; Santos da Silva, L. Y.; Alcântara, I. S.; Silva, T. M.; Silva, E. D. S.; Costa, R. H. S. D.; da Silva, 7. B.; Ribeiro-Filho, J.; Pereira Bezerra Martins, A. O. B.; Coutinho, H. D. M.; Sousa, J. C. P.; Chaves, A. R.; Marreto, R. N.; Menezes, I. R. A. D. Antinociceptive Potential of Ximenia americana L. Bark Extract and Caffeic Acid: Insights into Pain Modulation Pathways. Preprints 2024, 2024110552. https://doi.org/10.20944/preprints202411.0552.v1

Abstract

Ximenia americana L. (Olacaceae) has traditionally been used in folk medicine in the African continent and Brazilian Northeast to treat diseases such as diarrhea, fever, wounds, and pain. This study evaluated the antinociceptive effect of the Ximenia americana L. bark extract (HEXA) and its primary component, caffeic acid (CA), through in vivo assays. The antinociceptive properties were assessed using abdominal writhing, hot plate, and Von Frey tests. Additionally, the study investigated the modulation of various pain signaling pathways using a pharmacological approach. The results demonstrated that all doses of the HEXA extract significantly increased latency in the hot plate test, decreased the number of abdominal contortions, reduced hyperalgesia in the Von Frey test, and inhibited both phases of the formalin test. Caffeic acid reduced licking time in the first phase of the formalin test at all doses, with the highest dose showing significant effects in the second phase. The HEXA extract potentially modulated α2-adrenergic, nitric oxide, glutamatergic, vanilloid, cyclic guanosine monophosphate, and K+-ATP channel-dependent pathways. Conversely, caffeic acid influenced the opioid, glutamatergic, and vanilloid pathways while inhibiting nitric oxide and cyclic guanosine monophosphate. HEXA and CA exhibit significant antinociceptive effects due to their potential interference in multiple pain signaling pathways. While the molecular targets remain to be fully investigated, HEXA and CA demonstrate significant potential for the development of new analgesic drugs.

Keywords

Ximenia americana L.; caffeic acid; antinociceptive; anti-inflammatory; mechanism of action; pain

Subject

Medicine and Pharmacology, Pharmacology and Toxicology

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.